Lilly And Boehringer Ingelheim Announce Clinical Trial Collaboration In Metastatic Breast Cancer
Eli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of...
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen and Daiichi Sankyo Company announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in...
Spark Therapeutics and Pfizer receives FDA Designation for SPK-9001
Spark Therapeutics and Pfizer Inc announced that the U.S. FDA has granted breakthrough therapy designation to SPK-9001, the lead investigational candidate in the companies’...
AstraZeneca receives approval in the EU for Qtern for treatment of Type 2 diabetes
AstraZeneca announced that the EC has approved Qtern tablets for the treatment of type 2 diabetes in all 28 EU member countries plus Iceland,...
Tagrisso met primary endpoint in phase III 2nd-line lung cancer trial
AstraZeneca announced that the Phase III AURA3 trial met its primary endpoint, demonstrating superior progression-free survival (PFS) compared to standard platinum-based doublet chemotherapy. ...
Abbott laboratories says U.S. FDA approves tecnis symfony intraocular lenses
- Approval includes toric version of symfony iol for people with astigmatism- lenses provide high-quality continuous vision so patients can see clearly at near,...
Health Canada approves Abbott’s Absorb Bioresorbable Stent
Abbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people in...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...